With Start Of Sales Of Anti-Aging Skin Care At www.greysonintl.com, Greyson International, Inc. (OTC Pink Sheets: GYSN) CEO Keeps A Promise To A Cosmetics Titan

With Start Of Sales Of Anti-Aging Skin Care At www.greysonintl.com, Greyson International, Inc. (OTC Pink Sheets: GYSN) CEO Keeps A Promise To A Cosmetics Titan

COCONUT CREEK, Fla., July 8, 2014 /PRNewswire/ — With the fulfillment of orders this week at (www.greysonintl.com) for the Greyson Skin Care Three-Piece Kit with the revolutionary Trilexon® topical delivery system, Harvey Tauman keeps a promise he made to cosmetics industry titan, the late Charlie Fox.

Fox was the inventive chemist who developed the unique delivery system, which Tauman, CEO of Greyson International, Inc. (OTC Pink Sheets: GYSN) calls “the smart phone of the cosmetics industry.”

Tauman promised Fox, one of Warner-Lamberts’ most prolific product developers, that his dream for Trilexon® helping people worldwide would come true.

Greyson owns and secured a patent on these products containing Trilexon®, which are selling on www.greysonintl.com after years of development.

“Trilexon® will help people rejuvenate their skin like never before,” said Tauman who was founder and CEO of Hydron Technologies, Inc. when its stock on NASDAQ surged from 37 1/2 cents to $14.75, making it the biggest percentage gainer in 1983.

In April 1994, Tauman was chief spokesman of cosmetic and personal care products on QVC shopping channel, where he broke sales records, including $2.1M in one day of Hydron’s products.

The Greyson’s three-piece Skincare Kit with Trilexon® on sale for $99 contains a Perfect Balance Moisturizer, Clean Complex Foaming Cleanser and Pore Diminishing Toner each with Trilexon®, which releases pharmaceutical and anti-aging ingredients on the skin over extended periods. This technology supports the skins barrier layer which maintains a specific pH level on the skin and reduced moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems which continue to emulsify once applied on the skin and breaks down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

“Trilexon® is the single most important development in cosmetics in the past 50 years,” said Tauman.

About Greyson International, Inc. Trilexon® is a registered trademark of Greyson International, Inc. http://greysonintl.com. Facebook page:http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements resulting from a variety of factors including, but not limited to, risks and uncertainties associated with Greyson’s financial condition, its ability to sell products or compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission

Contacts: Greyson International, Inc., Harvey Tauman, 954-482-0497,Chief Executive Officer, Harvey@greysonintl.com, Media contact: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com

Greyson International, Inc. Announces the Untimely Death of Its Chairman and CEO

Greyson International, Inc. Announces the Untimely Death of Its Chairman and CEO

COCONUT CREEK, Fla., July 29, 2014 /PRNewswire/ — Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced that Harvey Tauman, the Company’s Chairman and CEO, passed away this morning unexpectedly. Mr. Tauman was 73 years old. He had been hospitalized recently for treatment of respiratory failure.

The Board of Directors issued the following statement: “We are greatly saddened by the passing of Harvey Tauman.  The Company’s directors and employees, as well as the many people he worked with over the years, mourn his loss.  We extend our sympathies to his family.”

C. Mukesh Prasad, the Company’s Director and Vice-President will preside as Chairman and CEO over the interim period.

Chaudhury Mukesh Prasad, Vice President 
Mr. Prasad has served as the Vice President of Operations for Greyson International, Inc. since 2003. He is now serving on the Board of Directors of the Company as well as Corporate Secretary and Executive Vice President. Previously employed for 25 years at Hydron Technologies, Inc., Mr. Prasad held the positions of Controller, Vice President, Corp. Secretary, and member of the board as well as other various operational roles.

Mr. Prasad brings significant hands on managerial experience to Greyson International, Inc.  He assists the Company with product development, production and launch of various skin care and hair care products.  He has extensive experience in business operations, accounting, purchasing, manufacturing, warehousing, fulfillment center, and human resources.  Mr. Prasad studied Physics, Chemistry and Math at collage in India and studied accounting, and management in USA.  He is also an active member of the Society of Cosmetic Chemist.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact
Greyson International Inc.
C. Mukesh Prasad, 954-482-0497
Interim Chief Executive Officer

Greyson International, Inc. (OTC Pink Sheets: GYSN) Announced Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care. Greyson says it’s a Clear Sign Company’s Moving Vigorously Forward after Death of Its Legendary CEO as He Had Wanted

Greyson International, Inc. (OTC Pink Sheets: GYSN) Announced Oct. 17 Canadian Kickoff on The Shopping Channel of Its Anti-Aging Skin Care.  Greyson says it’s a Clear Sign Company’s Moving Vigorously Forward after Death of Its Legendary CEO as He Had Wanted

COCONUT CREEK, Fla., September 30, 2014. — Greyson International, Inc. (OTC Pink Sheets: GYSN announced today the long-awaited TV launch of the Greyson Skin Care product line, with the patented Trilexon® topical delivery system, will be Oct. 17. It will receive four separate thirty (30) minute live TV airings that day on one of the leading interactive multi-channel retailers in North America, The Shopping Channel of Canada (tsc.ca), just as the company’s late CEO Harvey Tauman had planned prior to his death in July.

The well-known TV spokesperson Andrea Tilis will present the Greyson Skin Care kit on Oct. 17 at 9:30am, 1:30pm, 4:30pm and 8:30pm on The Shopping Channel seen throughout Canada. (All times are Eastern.)

“We’re excited to be carrying out the first of many things my father had planned to do as he believed so passionately.  Our skin care products with Trilexon are infinitely more effective and longer lasting than any other cosmetics,” said his son, Richard Tauman, Director of Operations of the company, now headed by Mukesh Prasad.  The company was founded by Harvey Tauman, who had held some of the most awesome cosmetics sales records in the history of TV home shopping.

Our technology supports the skins barrier layer and maintains a specific pH level on the skin to reduce moisture evaporation, thus promoting the ingredient penetration. Also, Trilexon’s® extended delivery of ingredients into the skin lasts longer.

In independent third party laboratory tests, performed by Peter T. Pugliese, M.D. and Zoe Diana Draelos, M.D., Trilexon® proved to deliver active ingredients at a consistent rate for extended periods. Unlike most emulsion systems once applied on the skin, it continues to emulsify and break down the barrier layer, the Greyson’s Trilexon® Delivery System stops emulsifying the essential oils and keeps the barrier layer intact.

About Greyson International, Inc.

Greyson’s patented Trilexon® delivery system, in addition to cosmetic applications, may have benefits in the medical field where it’s important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International Inc. Information is available http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with company’s financial condition, ability to sell its products and compete with competitors.  Please review other factors that may affect our future results on any current or future documents we file periodically with Securities & Exchange Commission.

Contacts:

Greyson International, Inc., Mukesh Prasad 954-482-0497, President, mukesh@greysonintl.com.

Media: Adrienne Mazzone 561-750-9800 x2270; amazzone@transmediagroup.com.

Greyson International Inc. Provides Update on its Energy Assets

Coconut Creek, Fla. – February 28, 2013 – Greyson International Inc. (OTC Pink: GYSN), developer of an innovative, patented topical delivery technology targeting the multi-billion dollar cosmetics and OTC pharmaceutical industries, today announced an update on its passive investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered oil and gas company with properties located in the country of Georgia.

“Greyson has been advised that the joint venture between Blake and the MND Group has been funded and new seismic data is being collected across all three properties. A drilling campaign is expected to commence later this year and continue through 2014.” said Greyson International Inc. CEO Harvey Tauman.

On March 12, 2012, Greyson acquired a private entity that resulted in a 3% passive ownership stake in Blake. On August 14, 2012, Blake entered into a joint venture agreement with MND Group whereby the latter received a 50% interest in Blake’s Georgian assets in exchange for assuming exploration and production costs. Under the terms of the agreement, the MND Group committed to over $100 million in capital expenditures to fund the development of the Ninotsminda, Manavi and Norio assets.

According to an independent report issued by Netherland, Sewell & Associates Inc. and Oilfield Production Consultants, these properties could have significant oil and gas reserves. More information about these assets can be found on Blake’s website, www.blakeoilandgas.com.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that’s taking the multi-billion dollar cosmetics and OTC pharmaceuticals industries by storm. Based on this technology, the company’s patented Trilexon® foundation creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. The company also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International, Inc. announces a tier upgrade of its common stock by OTC Markets and Shareholder Update

Coconut Creek, Fla. – December 27, 2012– Greyson International, Inc. (Pink Sheets: GYSN), developer of an innovative topical delivery technology, today announced that its common stock listed on OTC Markets has been upgraded to OTC Pink Current Information. The designation is for companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to OTC Markets Group Guidelines for Providing Adequate Current Information.

“Our goal is to transition Greyson International to a fully reporting company,” said Harvey Tauman, CEO of Greyson International Inc. “We are pleased that we have reached the highest tier in the OTC Pink Markets by completing and filing three years of audited financials in addition to having all of our quarterly filings released on time. Looking forward, we plan on moving towards an additional up listing to the OTCQB designation.”

Greyson is preparing a complete shareholder update to be released in the near future that will outline recent corporate developments, provide details about its Oil and Gas investment, as well as schedule a time for a shareholder conference call in early 2013.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that targets the multi-billion dollar cosmetics industry. It also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. The Trilexon® system creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; http://greysonintl.com and join the Greyson International’s Facebook page http://www.facebook.com/GreysonInternationalInc.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International, Inc. Unveils Revolutionary Color Treatment Product Utilizing Its Patented Trilexon® Delivery System

Coconut Creek, Fla. – November 7, 2012– Greyson International, Inc. (GYSN.PK) is entering into the $58.3 billion* cosmetic market with the creation of its new tinted Trilexon® foundation, designed to reduce fine lines that form around the eyes and mouth before applying make-ups, blushes and eye shadows. By providing an even tone, the Trilexon® foundation reduces blemishes, wrinkles, and fine lines providing a more uniform facial surface for color products. Trilexon® is the basis for many products utilizing the company’s patented delivery system, both in its existing product offerings and upcoming development pipeline.

“Trilexon® represents a breakthrough in the color cosmetic market that has eluded many of the world’s largest cosmetic companies for years,” said Harvey Tauman, CEO of Greyson International, Inc. “By creating a fine surface that’s insoluble in water, the foundation keeps in place with longer wear times despite sweat or water contact, while continuously releasing ingredients over an extended period of time to give skin a healthy and youthful look.”

Greyson’s Trilexon® technology uses a buffering system based on lactates. The pH is buffered to a range of 4.5-5.0, thus helping to maintain the skins natural pH. Maintaining the natural pH allows the natural intracellular cement of the skin cells to maintain their barrier function thereby promoting healthy skin by sustaining the natural moisture and lipid levels. Many naturally occurring enzymes that contribute to skin health and support healing, like betaglucocerebrosidase, are only active in the pH range of 4.5-5.0. The use of complexes like Dermaxyl and Metrixyl also help to plump the skin and reduce lines and wrinkles, resulting in skin smoothing. And finally, a cationic emulsifier with a prepolymer develops a water resistant film that helps promote moisture retention in the skin and minimize oil and sebum build-up over time.

“We are very excited to leverage our patented delivery system and bring our first color product to market in such a short timeframe,” added Mr. Tauman. “Trilexon® represents a breakthrough in the foundation and skin treatment space and we plan on launching several additional products next year in order to ramp up revenues and generate value for our shareholders.”

* Statistic from the Demeter Group.

About Greyson International, Inc.

Greyson’s primary focus is on its recently patented Trilexon® delivery system that targets the multi-billion dollar cosmetics industry. It also holds an investment in Blake Oil and Gas Limited (“Blake”), a privately owned, Guernsey registered, Oil and Gas Company. The Trilexon® system creates a fine surface that is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time, ensuring that the skin receives treatment at a constant steady pace to give it a healthy and youthful look. In addition to cosmetic applications, Trilexon® may also have benefits in the medical field where it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

Greyson International, Inc. announces its shares have officially become “DTC-Eligible”

Coconut Creek, Fla. – October 15, 2012– Greyson International, Inc. (GYSN.PK) has received notification from the Depository Trust & Clearing Corporation (“DTCC”) that its shares now have full service eligibility.

Greyson International CEO Harvey Tauman says “Now that our patent has been officially issued, our company can continue the process of shifting from a research and development company into a revenue-generating company. In accordance with our master plan of becoming a full reporting company we are pleased to announce that our securities now have the benefit of DTCC’s depository services. We are requesting that our shareholders notify their brokers of this important development and request that their shares be deposited with DTCC”.

About Greyson International, Inc.

Greyson’s main asset is its recently patented Trilexon® delivery system. It also holds an investment in Blake Oil and Gas Limited (“Blake”) a privately owned, Guernsey registered, Oil and Gas Company.  The Trilexon® delivery system precisely delivers key ingredients to the appropriate areas through “messengers” in order to achieve higher effectiveness and more noticeable results. The Trilexon® system creates a fine surface which is insoluble in water, keeping it in place even after sweating or contact with water. Ingredients are released continuously over an extended period of time; ensuring that the skin receives treatment at a constant steady pace to give the skin a healthy and youthful look. We believe that Trilexon® will have benefits in the medical field and wherever it is important to deliver active ingredients. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Greyson International, Inc. announces that today it filed to become DTC-Eligible, and in addition wants to invite investors to join its conference call tomorrow afternoon.

Coconut Creek, Fla. – September 19, 2012 – Greyson International, Inc. (GYSN.PK) filed today with the Depository Trust Company (“DTC”) to have its shares become “DTC-Eligible”.  This process, once effective, allows Greyson’s securities to have the benefit of DTC’s depository services.

Greyson will be holding an investor conference call on Thursday September 20, 2012, at 4:15 pm EDT.  The conference call dial in number is 530-881-1300. The Participant Access Code is 934487. The playback number is 530-881-1399.

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of active ingredients in most topical applications in today’s cosmetic and over-the-counter drug applications. Trilexon® is a registered trademark of Greyson International. For more information, visit our website; www.greysonintl.com and join the Greyson International’s Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Greyson International, Inc. Announces Details of its Investor Conference Call and its Updated Website

Coconut Creek, Fla. – September 14, 2012 – Greyson International, Inc. (GYSN.PK) will be holding an investor conference call  on September 20, 2012, at 4:15 pm EDT.  The conference call dial in number is 530-881-1300. The Participant Access Code is 934487. The playback number is 530-881-1399.

Greyson International CEO Harvey Tauman, “In addition to recent developments, we are proud to announce that we have updated our website (www.greysonintl.com), and encourage everyone to look at the new investor presentation to get a preview of the exciting things going on at Greyson.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Greyson has developed a new delivery method, the Trilexon® system, which will improve the effectiveness of virtually every topical application in today’s cosmetic market and every over-the-counter topical drug application. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

† Trilexon® is a registered trademark of Greyson International, Inc.

Greyson International, Inc. Receives Its Issue Date and Patent Number from the U.S. Patent and Trademark Office for its Breakthrough Trilexon® Delivery System Technology

Coconut Creek, Fla. – August 30, 2012– Greyson International, Inc. (GYSN.PK) announced today that it has received its issue date and Patent number from the U.S. Patent and Trademark Office.  The Patent will be issued on September 18, 2012 and the Patent Number is 8,268,335.

The Trilexon® Delivery System Technology, allows active ingredients to work for a longer period of time than other products currently available on the market, and therefore produces results never before possible. The Trilexon® delivery system can improve the effectiveness of virtually every topical application in almost any field imaginable.

Greyson International CEO, Harvey Tauman, said “We are very confident that this patent will support us in moving forward with marketing and licensing agreements wherever active ingredients are needed. This trans-dermal delivery system could be used more effectively in cosmetic, medical and veterinary use.”

The patent is classified as a “Utility” patent and, according to the US Patent Office; a utility patent is only obtained when the invention is for a “new and useful process, machine, manufacture, or composition of matter.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit www.greysonintl.com; join the Greyson Facebook group page by visiting www.facebook.com.

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.

Contact:

Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497

Harvey@greysonintl.com

 

† Trilexon® is a registered trademark of Greyson International, Inc.